Brennan VK - Search Results

1

Efficacy of transarterial radioembolization using Y-90 resin microspheres versus atezolizumab-bevacizumab in unresectable hepatocellular carcinoma: A matching-adjusted indirect comparison.

Agirrezabal I, Bouattour M, Pinato DJ, D'Alessio A, Brennan VK, Carion PL, Shergill S, Amoury N, Vilgrain V. Agirrezabal I, et al. Among authors: brennan vk. Eur J Cancer. 2024 Jan;196:113427. doi: 10.1016/j.ejca.2023.113427. Epub 2023 Nov 11. Eur J Cancer. 2024. PMID: 37988840 Free article.

2

Incorporating Process Utility into Cost-Effectiveness Analysis via a Bolt-On Domain to the SF-6D: An Exploratory Study.

Brennan VK, Jones G, Radley S, Dixon S. Brennan VK, et al. Appl Health Econ Health Policy. 2021 Sep;19(5):747-756. doi: 10.1007/s40258-021-00646-4. Epub 2021 Mar 30. Appl Health Econ Health Policy. 2021. PMID: 33782850 Free article.

3

Evaluating the impact of a 'virtual clinic' on patient experience, personal and provider costs of care in urinary incontinence: A randomised controlled trial.

Jones G, Brennan V, Jacques R, Wood H, Dixon S, Radley S. Jones G, et al. PLoS One. 2018 Jan 18;13(1):e0189174. doi: 10.1371/journal.pone.0189174. eCollection 2018. PLoS One. 2018. PMID: 29346378 Free PMC article. Clinical Trial.

4

Utility estimates for patients with Type 2 diabetes mellitus after experiencing a myocardial infarction or stroke: a systematic review.

Brennan VK, Mauskopf J, Colosia AD, Copley-Merriman C, Hass B, Palencia R. Brennan VK, et al. Expert Rev Pharmacoecon Outcomes Res. 2015 Feb;15(1):111-23. doi: 10.1586/14737167.2015.965152. Epub 2015 Jan 2. Expert Rev Pharmacoecon Outcomes Res. 2015. PMID: 25555462 Review.

5

A cost analysis of SIR-Spheres yttrium-90 resin microspheres versus tyrosine kinase inhibitors in the treatment of unresectable hepatocellular carcinoma in France, Italy, Spain and the UK.

Pollock RF, Colaone F, Guardiola L, Shergill S, Brennan VK. Pollock RF, et al. Among authors: brennan vk. J Med Econ. 2020 Jun;23(6):593-602. doi: 10.1080/13696998.2020.1731213. Epub 2020 May 1. J Med Econ. 2020. PMID: 32067534 Free article.

6

A cost-utility analysis of SIR-Spheres Y-90 resin microspheres versus best supportive care in the treatment of unresectable metastatic colorectal cancer refractory to chemotherapy in the UK.

Brennan VK, Colaone F, Shergill S, Pollock RF. Brennan VK, et al. J Med Econ. 2020 Dec;23(12):1588-1597. doi: 10.1080/13696998.2020.1839273. Epub 2020 Dec 2. J Med Econ. 2020. PMID: 33084466 Free article.

7

A systematic literature review and network meta-analysis of first-line treatments for unresectable hepatocellular carcinoma based on data from randomized controlled trials.

Pollock RF, Brennan VK, Shergill S, Colaone F. Pollock RF, et al. Among authors: brennan vk. Expert Rev Anticancer Ther. 2021 Mar;21(3):341-349. doi: 10.1080/14737140.2021.1842204. Epub 2021 Feb 10. Expert Rev Anticancer Ther. 2021. PMID: 33131346

8

Cost-utility analysis of selective internal radiation therapy with Y-90 resin microspheres in hepatocellular carcinoma.

Muszbek N, Remak E, Evans R, Brennan VK, Colaone F, Shergill S, Mullan D, Ross PJ. Muszbek N, et al. Among authors: brennan vk. Future Oncol. 2021 Mar;17(9):1055-1068. doi: 10.2217/fon-2020-1004. Epub 2020 Nov 23. Future Oncol. 2021. PMID: 33222542 Free article.

9

Patient preferences for advanced hepatocellular carcinoma treatment: a multicountry stated preference study.

Lo SH, Sharma R, Costentin CE, Aggio D, Shergill S, Colaone F, Brennan VK, Straccia VA, Agirrezabal I, Lloyd AJ. Lo SH, et al. Among authors: brennan vk. Future Oncol. 2021 Nov;17(32):4275-4287. doi: 10.2217/fon-2021-0697. Epub 2021 Jul 27. Future Oncol. 2021. PMID: 34313150 Free article.

10

Changes in treatment pattern and costs in advanced hepatocellular carcinoma (HCC).

Muszbek N, Evans R, Remak E, Brennan VK, Colaone F, Shergill S, Ross P, Mullan D. Muszbek N, et al. Among authors: brennan vk. Expert Rev Pharmacoecon Outcomes Res. 2022 Jan;22(1):147-154. doi: 10.1080/14737167.2021.1973892. Epub 2021 Sep 6. Expert Rev Pharmacoecon Outcomes Res. 2022. PMID: 34488517

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page